OSE Immunotherapeutics Publishes Letter to Shareholders
Globenewswire·2025-06-30 16:00
OSE Immunotherapeutics Publishes Letter to Shareholders NANTES, France, June 30, 2025, 6:00 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces the publication of its inaugural Letter to Shareholders. The Company’s CEO and Board of Directors wish to share with shareholders the key achievements of recent months, the foundations of its growth strategy and perspectives for the future. The Letter to Shareholders is available on the Company's website: https://tinyurl.com/2n3rhnpn. ABOU ...